Treatment
Dihydroartemisinin clinical trials
We’re tracking 9 recruiting studies that include Dihydroartemisinin, each written for real people, not researchers, below.
Recruiting studies
- NCT07679542RecruitingPhase 1/Phase 2
Dihydroartemisinin for metabolic fatty liver disease
This trial tests whether dihydroartemisinin, a malaria drug that may reduce liver fat, helps people with metabolic fatty liver disease. It is for adults aged 18 to 45 who have a fatty liver and at least one metabolic problem like overweight, high blood pressure, or diabetes.
Nanjing, JiangsuAges 18–45 - NCT06842524RecruitingPhase 2
Dihydroartemisinin for PCOS: A Phase 2 Trial
This trial tests if dihydroartemisinin (a medicine derived from a plant) can help women with PCOS. It may improve hormone balance and menstrual cycles.
Xiamen, FujianAges 18–40 - NCT07007078RecruitingEarly Phase 1
Dihydroartemisinin for acne vulgaris
This study tests if a medicine called dihydroartemisinin (a type of artemisinin, often used for malaria) can help treat acne when applied to the skin. It's a small early-phase trial for people with acne vulgaris.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT07021430RecruitingEarly Phase 1
Preventing Malaria in Pregnancy with Focal Drug Treatment
This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.
KaseseAges Any age - NCT04704999RecruitingPhase 4
Testing the right tafenoquine dose for malaria prevention
This study tests the best dose of tafenoquine to treat people with symptoms from a malaria type called P. vivax and to help prevent it from coming back. You may be eligible if you recently had fever and meet specific blood and safety checks, especially G6PD level.
Siem ReapAges 2 years+ - NCT05788094RecruitingPhase 4
Compare two medicines for P. vivax malaria
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
Mae Sot, Changwat TakAges 18 years+ - NCT06962319RecruitingPhase 3
Malaria treatment safety in early pregnancy
This trial tests how safe antimalarial drugs are during the first few months of pregnancy. It aims to find treatments that protect both mother and baby.
NanoroAges 16 years+ - NCT07012486RecruitingEarly Phase 1
Dihydroartemisinin for female hair loss
This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT07389057Recruiting
Malaria prevention study with combined medicines in Ghana
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
Accra, Eastern RegionAges 3 months+
What Dihydroartemisinin is being studied for
Conditions with recruiting Dihydroartemisinin studies.
Common questions
- Are there clinical trials studying Dihydroartemisinin?
- Yes. Clin2 currently lists 9 recruiting studies that include Dihydroartemisinin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Dihydroartemisinin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Dihydroartemisinin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Dihydroartemisinin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.